Literature DB >> 18845523

Clinical problems after initial unplanned resection of sarcoma.

Manabu Hoshi1, Makoto Ieguchi, Masatsugu Takami, Masanari Aono, Susumu Taguchi, Takaaki Kuroda, Kunio Takaoka.   

Abstract

OBJECTIVE: Unplanned resection of a sarcoma is often chosen in the early phase by general physicians without any imaging scrutiny. The present study aimed to highlight the clinical problems associated with unplanned resection of sarcomas.
METHODS: Thirty-eight patients who underwent unplanned resection of a sarcoma and additional treatment were examined. The definite histological grading was high in 31 patients and low in 7 patients.
RESULTS: The tumors were located in the depth of the subfascia in 13 patients. The maximal tumor sizes exceeded 5 cm in 16 patients. Preoperative MRI was only performed in six patients. The previous surgical margins were intralesional in 20 patients and marginal in 18 patients. Inappropriate transverse skin incisions were found in 21 patients. Extensive hematoma at the initial surgical site was seen in five patients. Thirty-three patients accepted additional wide resection due to the insufficient removal of malignancy. During an average follow-up of 42.7 months, seven patients died of lung and brain metastases.
CONCLUSIONS: On excision of any soft tissue tumor, surgeons should be aware of the potential risk for erroneous management of malignancy. If not, careless surgery may render the treatment protocol complicated and require excessive additional tissue resection with poor function and prognosis. Appropriate salvage treatment may have a significant role to play after unplanned resection of the sarcoma.

Entities:  

Mesh:

Year:  2008        PMID: 18845523     DOI: 10.1093/jjco/hyn093

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

Review 2.  Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy.

Authors:  Nisreen S Ezuddin; Juan Pretell-Mazzini; Raphael L Yechieli; Darcy A Kerr; Breelyn A Wilky; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2018-05-21       Impact factor: 2.199

3.  How should orthopaedic oncologists prevent unplanned resections of soft tissue sarcomas by general practitioners?

Authors:  Kazuo Mochizuki
Journal:  J Orthop Sci       Date:  2012-07       Impact factor: 1.601

4.  Comparative study of planned and unplanned excisions for the treatment of soft tissue sarcoma of the extremities.

Authors:  Carlos E H Hanasilo; Marcelo S Casadei; Leandro Auletta; Eliane M I Amstalden; Silvia R F Matte; Mauricio Etchebehere
Journal:  Clinics (Sao Paulo)       Date:  2014-09       Impact factor: 2.365

5.  Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall.

Authors:  Hina Saeed; David M King; Candice A Johnstone; John A Charlson; Donald A Hackbarth; John C Neilson; Manpreet Bedi
Journal:  Int J Surg Oncol       Date:  2016-10-10

6.  Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.

Authors:  Maria Anna Smolle; Dimosthenis Andreou; Per-Ulf Tunn; Joanna Szkandera; Bernadette Liegl-Atzwanger; Andreas Leithner
Journal:  EFORT Open Rev       Date:  2017-10-17

7.  Impact of unplanned excision on prognosis of patients with extremity soft tissue sarcoma.

Authors:  Hafiz Muhammad Umer; Masood Umer; Irfan Qadir; Nadeem Abbasi; Nehal Masood
Journal:  Sarcoma       Date:  2013-04-30

8.  Diagnostic value of tumor-fascia relationship in superficial soft tissue masses on magnetic resonance imaging.

Authors:  Tadashi Iwai; Manabu Hoshi; Naoto Oebisu; Masanari Aono; Masatugu Takami; Makoto Ieguchi; Hiroaki Nakamura
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.